Research style and rationale pertaining to Optimal aNtiplatelet pharmacotherapy carefully guided simply by study in bed innate or even well-designed Screening throughout suggested percutaneous coronary input sufferers (ONSIDE TEST): a prospective, open-label, randomised parallel-group multicentre demo (NCT01930773).